ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
38.82
-0.49%
US Tech 100
18,907.20
-0.01%
S&P 500
5,572.07
-0.76%
US Dollar vs CAD
1.44117
-0.13%
Bitcoin
82,604.23
5.26%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. IceCure Medical Ltd (ICCM)

  7. IceCure Medical Ltd (ICCM) News

ICCM

IceCure Medical (ICCM)

IceCure Medical Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ICCM
DateTimeSourceHeadlineSymbolCompany
03/10/20257:35AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ICCMIceCure Medical Ltd
03/10/20257:30AMPR Newswire (US)Breast Cancer Patients who Underwent IceCure's ProSense® Cryoablation in Japan Reported Significantly Higher Satisfaction than Patients who Underwent Standard of Care SurgeryNASDAQ:ICCMIceCure Medical Ltd
02/24/20257:40AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ICCMIceCure Medical Ltd
02/24/20257:30AMPR Newswire (US)IceCure Submits Filing for Regulatory Approval of its Next-Generation XSense™ Cryoablation System in IsraelNASDAQ:ICCMIceCure Medical Ltd
02/04/20257:35AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ICCMIceCure Medical Ltd
02/04/20257:30AMPR Newswire (US)IceCure's ProSense® in the Spotlight at Society of Interventional Oncology (SIO) Annual Meeting: Award Winning Abstract and Hands-On Training for Breast Cryoablation as Medical Community Anticipates FDA's Market Authorization DecisionNASDAQ:ICCMIceCure Medical Ltd
01/27/20257:40AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ICCMIceCure Medical Ltd
01/27/20257:30AMPR Newswire (US)IceCure Files for Regulatory Approval of ProSense® Cryoablation System in ChinaNASDAQ:ICCMIceCure Medical Ltd
01/13/20257:21AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ICCMIceCure Medical Ltd
01/13/20256:59AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ICCMIceCure Medical Ltd
01/13/20256:16AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ICCMIceCure Medical Ltd
01/13/20256:00AMPR Newswire (US)IceCure Medical CEO Issues Letter to Shareholders & Reports Increase of 42% in ProSense® Sales for 2024 in North AmericaNASDAQ:ICCMIceCure Medical Ltd
01/06/20257:40AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ICCMIceCure Medical Ltd
01/06/20257:30AMPR Newswire (US)IceCure Medical Regains Full Nasdaq Compliance with Nasdaq Minimum Closing Bid Price RuleNASDAQ:ICCMIceCure Medical Ltd
01/03/20257:35AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ICCMIceCure Medical Ltd
01/03/20257:30AMPR Newswire (US)European Patent Office Issues Intention to Grant Notice to IceCure for its Next-Generation Cryoablation TechnologyNASDAQ:ICCMIceCure Medical Ltd
12/30/20247:42AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ICCMIceCure Medical Ltd
12/16/20247:30AMPR Newswire (US)Data on IceCure's ProSense® Cryoablation for Low-Risk Breast Cancer Presented at Radiological Society of North America's 2024 Annual MeetingNASDAQ:ICCMIceCure Medical Ltd
12/05/20247:35AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ICCMIceCure Medical Ltd
12/05/20247:30AMPR Newswire (US)IceCure's ProSense® Cryoablation Safe and Effective in Destruction of Kidney Tumors with 88.7% Recurrence-Free Rate Based on Interim ICESECRET Study ResultsNASDAQ:ICCMIceCure Medical Ltd
11/26/20247:35AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ICCMIceCure Medical Ltd
11/26/20247:30AMPR Newswire (US)IceCure Medical Reports 36% Sales Growth in the First Nine Months of 2024 Driven by Global Adoption of ProSense® CryoablationNASDAQ:ICCMIceCure Medical Ltd
11/25/20247:50AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ICCMIceCure Medical Ltd
11/25/20247:30AMPR Newswire (US)IceCure's Next-Generation Multiprobe Cryoablation Technology Issued Notice of Allowance from Japan's Patent OfficeNASDAQ:ICCMIceCure Medical Ltd
11/20/20247:30AMPR Newswire (US)IceCure Medical to Report Third Quarter 2024 Financial & Operational Results on November 26, 2024NASDAQ:ICCMIceCure Medical Ltd
11/19/20247:30AMPR Newswire (US)IceCure's ProSense® Chosen for Breast Cryoablation Study Led by the Prestigious European Institute of Oncology with Sponsorship from the Italian Ministry of HealthNASDAQ:ICCMIceCure Medical Ltd
11/14/20248:38PMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ICCMIceCure Medical Ltd
11/08/20249:05AMEdgar (US Regulatory)Form F-1/A - Registration statement for certain foreign private issuers: [Amend]NASDAQ:ICCMIceCure Medical Ltd
11/08/20246:08AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ICCMIceCure Medical Ltd
11/08/20246:00AMPR Newswire (US)FDA Advisory Panel Votes in Favor of IceCure's ProSense® Cryoablation Benefit-Risk Profile in Early-Stage Low Risk Breast CancerNASDAQ:ICCMIceCure Medical Ltd
 Showing the most relevant articles for your search:NASDAQ:ICCM

Your Recent History

BIT
3SSP
Graniteshares 3x Short I...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads